http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-421570-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b4beef0c137d9094e6918ee382be22f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0094
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
filingDate 1973-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1977-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-421570-A1
titleOfInvention A PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF CYANOPREGNENONE.
abstract A method for lowering elevated serum lipid concentrations comprising administering a composition containing, as the active ingredient, a 3 beta -substituted-16 alpha -cyanopreg-5-en-20-one wherein the substituent at the 3 beta -position is selected from the group consisting of hydroxy, alkoxy having 1 to 6 carbon atoms, cycloalkoxy having 3 to 6 carbon atoms, acyloxy wherein the acyl moiety has 2 to 7 carbon atoms, tetrahydrofuran-2'-yloxy, tetrahydropyran-2'-yloxy, and 4'-alkoxytetrahydropyran-4'-yloxy where the alkoxy moiety has 1 to 6 carbon atoms. Representative active ingredients are 3 beta -acetoxy-16 alpha -cyanopreg-5-en-20-one and 3 beta -cyclopentyloxy-16 alpha -cyanopregn-5-en-20-one. These representative agents are also useful in the therapeutic method of protecting and regenerating damaged hepatic tissue.
priorityDate 1972-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 16.